Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in thrombopoietin

Blood

Volumn 130, Issue 7, 2017, Pages 875-880

  Seo, Aaron ^a,b   Ben Harosh, Miri ^c   Sirin, Mehtap ^d   Stein, Jerry ^e,f   Dgany, Orly ^f   Kaplelushnik, Joseph ^c   Hoenig, Manfred ^d   Pannicke, Ulrich ^g   Lorenz, Myriam ^g   Schwarz, Klaus ^g,h   Stockklausner, Clemens ⁱ   Walsh, Tom ^a,b   Gulsuner, Suleyman ^a,b   Lee, Ming K ^a,b   Sendamarai, Anoop ^j   Sanchez Bonilla, Marilyn ^k   King, Mary Claire ^a,b   Cario, Holger ^d   Kulozik, Andreas E ⁱ   Debatin, Klaus Michael ^d   Schulz, Ansgar ^d   Tamary, Hannah ^f   Shimamura, Akiko ^k   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

^g UNIVERSITY OF ULM   (Germany)

^h German Red Cross Blood Donation Service Baden Wuerttemberg Hessen   (Germany)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; ROMIPLOSTIM; STEROID; THROMBOPOIETIN; THYMOCYTE ANTIBODY; FC RECEPTOR; HYBRID PROTEIN;

ARTICLE; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CASE REPORT; CAUSE OF DEATH; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CONTROLLED STUDY; EMBRYO; ENGRAFTMENT; FAMILY; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HEMATOPOIESIS; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LOSS OF FUNCTION MUTATION; MALE; MEGALOCYTOSIS; NEUTROPENIA; PANCYTOPENIA; PEDIGREE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULOCYTE COUNT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT FAILURE; BONE MARROW; GENETICS; HEK293 CELL LINE; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; TREATMENT OUTCOME;

BASE SEQUENCE; BONE MARROW; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEK293 CELLS; HUMANS; INFANT; MALE; MUTATION; PEDIGREE; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; THROMBOPOIETIN; TREATMENT OUTCOME;

EID: 85027871624     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2017-02-768036     Document Type: Article

References (31)

1. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24(3):101-122.
2. Parikh S, Bessler M. Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr. 2012;24(1):23-32.
3. Zhang MY, Keel SB, Walsh T, et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica. 2015;100(1):42-48.
4. Krissinel E, Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr Sect D Biol Crystallogr. 2004; 60(Pt 12 Pt 1):2256-2268.
5. The PyMOL Molecular Graphics System, Version 1.8. Schrodinger LLC; 2015.
6. Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 1994;77(7): 1117-1124.
7. Linden HM, Kaushansky K. The glycan domain of thrombopoietin enhances its secretion. Biochemistry. 2000;39(11):3044-3051.
8. Muto T, Feese MD, Shimada Y, et al. Functional analysis of the C-terminal region of recombinant human thrombopoietin. C-terminal region of thrombopoietin is a “shuttle” peptide to help secretion. J Biol Chem. 2000;275(16): 12090-12094.
9. Linden HM, Kaushansky K. The glycan domain of thrombopoietin (TPO) acts in trans to enhance secretion of the hormone and other cytokines. J Biol Chem. 2002;277(38):35240-35247.
10. Wolber EM, Dame C, Fahnenstich H, et al. Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood. 1999;94(1): 97-105.
11. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood. 1997;89(1):101-107.
12. Foster DC, Sprecher CA, Grant FJ, et al. Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA. 1994;91(26):13023-13027.
13. Sungaran R, Chisholm OT, Markovic B, Khachigian LM, Tanaka Y, Chong BH. The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood. 2000; 95(10):3094-3101.
14. Dasouki MJ, Rafi SK, Olm-Shipman AJ, et al. Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia. Blood. 2013;122(20):3440-3449.
15. Mandrile G, Dubois A, Hoffman JD, et al. 3q26.33-3q27.2 microdeletion: a new microdeletion syndrome? Eur J Med Genet. 2013;56(4): 216-221.
16. Zeigler FC, de Sauvage F, Widmer HR, et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood. 1994;84(12): 4045-4052.
17. Zhang B, Ng D, Jones C, et al. A novel splice donor mutation in the thrombopoietin gene leads to exon 2 skipping in a Filipino family with hereditary thrombocythemia. Blood. 2011; 118(26):6988-6990.
18. Kondo T, Okabe M, Sanada M, et al. Familial essential thrombocythemia associated with one-base deletion in the 59-untranslated region of the thrombopoietin gene. Blood. 1998;92(4): 1091-1096.
19. Liu K, Kralovics R, Rudzki Z, et al. A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica. 2008;93(5):706-714.
20. Gotlib J, Zhang B, Jones CD, et al. Identification of a novel splice donor mutation in the thrombopoietin gene in a Philippine family with hereditary thrombocythemia [abstract]. Blood. 2010;116(21). Abstract 3086.
21. Ihara K, Ishii E, Eguchi M, et al. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci USA. 1999;96(6):3132-3136.
22. Ballmaier M, Germeshausen M, Schulze H, et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001; 97(1):139-146.
23. Walne AJ, Dokal A, Plagnol V, et al. Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica. 2012;97(4):524-528.
24. Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost. 2011;37(6):673-681.
25. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science. 1994;265(5177):1445-1447.
26. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996; 87(6):2162-2170.
27. Carver-Moore K, Broxmeyer HE, Luoh SM, et al. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood. 1996;88(3):803-808.
28. Russell ES, Bernstein SE, Lawson FA, Smith LJ. Long-continued function of normal blood-forming tissue transplanted into genetically anemic hosts. J Natl Cancer Inst. 1959;23(3):557-566.
29. Dexter TM, Moore MAS. In vitro duplication and “cure” of haemopoietic defects in genetically anaemic mice. Nature. 1977;269(5627):412-414.
30. Bernstein SE. Tissue transplantation as an analytic and therapeutic tool in hereditary anemias. Am J Surg. 1970;119(4):448-451.
31. Wolf NS. Dissecting the hematopoietic microenvironment. III. Evidence for a positive short range stimulus for cellular proliferation. Cell Tissue Kinet. 1978;11(4):335-345.